Moderna and Merck’s cancer vaccine reduces the risk of recurrence or death by 44%, with promising results in a melanoma trial.
Advancements in cancer therapies have been nothing short of remarkable in recent years, with ongoing research and development paving the way to more effective and innovative treatments. Now, a collaboration between Moderna and Merck may offer even greater hope for patients with cancer. The two pharmaceutical giants have created a unique combo cancer-vaccine treatment that … Read more